INS and metabolic dysfunction-associated steatohepatitis: Bioinformatic analysis predicted alterations in secreted proteins that impact various aspects of lipid metabolism (e.g., fatty acid metabolism, lipid synthesis, lipid export), and our own experiments in cultured cells support the likelihood that NASH-induced hepatokines contribute to altered systemic lipid metabolism and insulin action (Fig. 1).